AngioDynamics Stock Buy Hold or Sell Recommendation

ANGO
 Stock
  

USD 12.25  0.12  0.97%   

Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding AngioDynamics is 'Hold'. Macroaxis provides AngioDynamics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ANGO positions. The advice algorithm takes into account all of AngioDynamics' available fundamental, technical, and predictive indicators you will find on this site.
  
The advice is provided from AngioDynamics' buy-and-hold perspective. Please continue to AngioDynamics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as AngioDynamics and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards AngioDynamics.

Execute AngioDynamics Buy or Sell Advice

The AngioDynamics recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on AngioDynamics. Macroaxis does not own or have any residual interests in AngioDynamics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute AngioDynamics' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell AngioDynamicsBuy AngioDynamics
Hold

Volatility

Details

Hype Condition

Details

Current Valuation

Details

Odds of Distress

Details

Economic Sensitivity

Details

Analyst Consensus

Details

Financial Strenth (F Score)

Details

Financial Leverage

Inapplicable
Details

Reporting Quality (M-Score)

Details
For the selected time horizon AngioDynamics has a Risk Adjusted Performance of (0.28), Jensen Alpha of (0.86), Total Risk Alpha of (0.93) and Treynor Ratio of (0.62)
Our trade advice tool can cross-verify current analyst consensus on AngioDynamics and to analyze the company potential to grow in the current economic cycle. To make sure AngioDynamics is not overpriced, please confirm all AngioDynamics fundamentals, including its cash per share, number of employees, and the relationship between the revenue and cash flow from operations . Given that AngioDynamics has a price to earning of 7.90 X, we suggest you to validate AngioDynamics market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

AngioDynamics Trading Alerts and Improvement Suggestions

AngioDynamics generated a negative expected return over the last 90 days
AngioDynamics has high historical volatility and very poor performance
The company reported the previous year's revenue of 316.22 M. Net Loss for the year was (26.55 M) with profit before overhead, payroll, taxes, and interest of 164.93 M.
AngioDynamics currently holds about 24.56 M in cash with (7.19 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.31.
AngioDynamics has a poor financial position based on the latest SEC disclosures
Over 96.0% of the company shares are held by institutions such as insurance companies
Latest headline from news.google.com: AngioDynamics, Inc. Is Breakeven Near - Simply Wall St

AngioDynamics Returns Distribution Density

The distribution of AngioDynamics' historical returns is an attempt to chart the uncertainty of AngioDynamics' future price movements. The chart of the probability distribution of AngioDynamics stock daily returns describes the distribution of returns around its average expected value. We use AngioDynamics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of AngioDynamics returns is essential to provide solid investment advice for AngioDynamics.
Mean Return-0.77Value At Risk-8.3
Potential Upside4.45Standard Deviation3.96
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of AngioDynamics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

AngioDynamics Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as AngioDynamics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading AngioDynamics backward and forwards among themselves. AngioDynamics' institutional investor refers to the entity that pools money to purchase AngioDynamics' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Zurcher Kantonalbank Zurich CantonalbankCommon Shares5.3 K109 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares5.3 K103 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares5.3 K115 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares5.3 K147 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares5.3 K138 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares5.3 K145 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares5.3 K125 K
Note, although AngioDynamics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

AngioDynamics Cash Flow Accounts

201720182019202020212022 (projected)
Capital Expenditure(2.39 M)(3.12 M)(7.24 M)(13.71 M)(15.71 M)(16.12 M)
Depreciation Amortization and Accretion23.16 M25.88 M25.88 M28.37 M31.79 M31.89 M
Net Cash Flow or Change in Cash and Cash Equivalents26.55 M153.54 M(173.21 M)(6.27 M)(19.34 M)(19.84 M)
Issuance Purchase of Equity Shares2.95 M2.03 M(759 K)3.01 M2.68 M2.18 M
Net Cash Flow from Financing(11.55 M)33.93 M(95.24 M)(16.99 M)7.68 M8.29 M
Net Cash Flow from Investing(3.66 M)82.55 M(63.34 M)(13.71 M)(19.31 M)(20.83 M)
Net Cash Flow from Operations41.29 M37.44 M(14.55 M)24.09 M(7.19 M)(7.38 M)
Share Based Compensation7.91 M9.25 M7.59 M8.62 M10.69 M9.39 M

AngioDynamics Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to AngioDynamics or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that AngioDynamics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a AngioDynamics stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over NYSE Composite
-0.86
β
Beta against NYSE Composite1.27
σ
Overall volatility
3.99
Ir
Information ratio -0.21

AngioDynamics Volatility Alert

AngioDynamics exhibits very low volatility with skewness of -1.94 and kurtosis of 7.0. However, we advise investors to further study AngioDynamics technical indicators to ensure that all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure AngioDynamics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact AngioDynamics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

AngioDynamics Fundamentals Vs Peers

Comparing AngioDynamics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze AngioDynamics' direct or indirect competition across all of the common fundamentals between AngioDynamics and the related equities. This way, we can detect undervalued stocks with similar characteristics as AngioDynamics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of AngioDynamics' fundamental indicators could also be used in its relative valuation, which is a method of valuing AngioDynamics by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare AngioDynamics to competition
FundamentalsAngioDynamicsPeer Average
Return On Equity(0.08) %(0.31) %
Return On Asset(0.0274) %(0.14) %
Profit Margin(0.10) %(1.27) %
Operating Margin(0.08) %(5.51) %
Current Valuation502.35 M16.62 B
Shares Outstanding39.11 M571.82 M
Shares Owned by Insiders5.03 %10.09 %
Shares Owned by Institutions96.22 %39.21 %
Number of Shares Shorted958.69 K4.71 M
Price to Earning7.90 X28.72 X
Price to Book1.15 X9.51 X
Price to Sales1.48 X11.42 X
Revenue316.22 M9.43 B
Gross Profit164.93 M27.38 B
EBITDA88 K3.9 B
Net Income(26.55 M)570.98 M
Cash and Equivalents24.56 M2.7 B
Cash per Share0.31 X5.01 X
Total Debt25 M5.32 B
Debt to Equity0.14 %48.70 %
Current Ratio2.28 X2.16 X
Book Value Per Share10.49 X1.93 K
Cash Flow from Operations(7.19 M)971.22 M
Short Ratio1.79 X4.00 X
Earnings Per Share(1.02) X3.12 X
Price to Earnings To Growth1.87 X4.89 X
Target Price26.5
Number of Employees76018.84 K
Beta0.7-0.15
Market Capitalization474.38 M19.03 B
Total Asset552.75 M29.47 B
Retained Earnings64.54 M9.33 B
Working Capital79.53 M1.48 B
   Purchase by Stephen Trowbridge of 1083 shares of Angiodynamics [view details]

AngioDynamics Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as AngioDynamics . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About AngioDynamics Buy or Sell Advice

When is the right time to buy or sell AngioDynamics? Buying financial instruments such as AngioDynamics Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2019 2020 2021 2022 (projected)
Receivables34.17 M35.41 M52.3 M46.27 M
Inventories59.91 M48.61 M51.39 M48.28 M

Use Investing Ideas to Build Portfolios

In addition to having AngioDynamics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Education Thematic Idea Now

Education
Education Theme
Companies involved in apprenticeship, education, tutoring, schooling, online universities, and other learning services. The Education theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Education Theme or any other thematic opportunities.
View All  Next Launch
Please continue to AngioDynamics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the AngioDynamics information on this page should be used as a complementary analysis to other AngioDynamics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Transaction History module to view history of all your transactions and understand their impact on performance.

Complementary Tools for AngioDynamics Stock analysis

When running AngioDynamics price analysis, check to measure AngioDynamics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AngioDynamics is operating at the current time. Most of AngioDynamics' value examination focuses on studying past and present price action to predict the probability of AngioDynamics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move AngioDynamics' price. Additionally, you may evaluate how the addition of AngioDynamics to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Is AngioDynamics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
474.4 M
Quarterly Revenue Growth YOY
0.059
Return On Assets
(0.0274) 
Return On Equity
(0.08) 
The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine AngioDynamics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.